169 related articles for article (PubMed ID: 3418510)
1. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
[TBL] [Abstract][Full Text] [Related]
2. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
[TBL] [Abstract][Full Text] [Related]
3. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
[TBL] [Abstract][Full Text] [Related]
4. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
Terao N; Shen DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
[TBL] [Abstract][Full Text] [Related]
5. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
[TBL] [Abstract][Full Text] [Related]
6. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A
Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248
[TBL] [Abstract][Full Text] [Related]
7. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
Siebert GA; Hung DY; Chang P; Roberts MS
J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
[TBL] [Abstract][Full Text] [Related]
8. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
[TBL] [Abstract][Full Text] [Related]
10. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
11. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
[TBL] [Abstract][Full Text] [Related]
12. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
Fenyves D; Gariépy L; Villeneuve JP
Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
[TBL] [Abstract][Full Text] [Related]
13. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
Oie S; Fiori F
J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
[TBL] [Abstract][Full Text] [Related]
14. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
Hallifax D; Houston JB
Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
[TBL] [Abstract][Full Text] [Related]
15. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
Chindavijak B; Belpaire FM; Bogaert MG
Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
[TBL] [Abstract][Full Text] [Related]
16. Age and gender influence the stereoselective pharmacokinetics of propranolol.
Gilmore DA; Gal J; Gerber JG; Nies AS
J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
[TBL] [Abstract][Full Text] [Related]
17. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
Chindavijak B; Belpaire FM; Bogaert MG
J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
Kiriyama A; Honbo A; Iga K
Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
